Live Vaccine PULVAC BURSA F

Infectious bursal disease (IBD or Gumboro disease) is one of the most serious threats in poultry farming. It damages the immune system of birds and makes them vulnerable to other infections. To effectively control this threat, the company Zoetis has developed the live dry vaccine PULVAC BURSA F. The vaccine is based on an attenuated IBD virus (strain V877) grown on clean SPF chicken embryos, which ensures high biological purity and effectiveness of vaccination.

The main advantage of the PULVAC BURSA F vaccine for industrial poultry farming is the high invasiveness of the vaccine strain, which allows it to spread quickly among birds. The vaccine provides reliable protection not only against the clinical signs of the disease but also against hidden subclinical forms that often cause economic losses.

Another important feature of the vaccine is its gentle effect on the organism. It does not suppress the immune system and helps the bursa of Fabricius recover quickly after vaccination, maintaining a high immune status of the flock.

Introducing PULVAC BURSA F into the veterinary protocol of your poultry farm guarantees stability and safety of production. A single administration through drinking water forms an active immune response within 14 days and provides protection for at least 3 months.